Is CorMedix Inc. (CRMD) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.1% / 30% | 10.2% / 30% | 10.1% / 30% | 5.93% / 5% | ✗ NOT HALAL |
| DJIM | 0.1% / 33% | 10.2% / 33% | 10.1% / 33% | 5.93% / 5% | ✗ NOT HALAL |
| MSCI | 0.4% / 33% | 43.5% / 33% | 43.5% / 33% | 5.93% / 5% | ✗ NOT HALAL |
| S&P | 0.1% / 33% | 10.2% / 33% | 10.1% / 33% | 5.93% / 5% | ✗ NOT HALAL |
| FTSE | 0.4% / 33% | 43.5% / 33% | 43.5% / 50% | 5.93% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 92.9% | |
| Operating Margin | 53.9% | |
| Net Margin | 52.3% | |
| Return on Equity (ROE) | 66.6% | |
| Return on Assets (ROA) | 21.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $175M |
| Free Cash Flow | $173M |
| Total Debt | $149M |
| Debt-to-Equity | 36.7 |
| Current Ratio | 2.1 |
| Total Assets | $826M |
Price & Trading
| Last Close | $6.70 |
| 50-Day MA | $7.09 |
| 200-Day MA | $10.53 |
| Avg Volume | 2.6M |
| Beta | 1.4 |
|
52-Week Range
$5.60
| |
About CorMedix Inc. (CRMD)
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is CorMedix Inc. (CRMD) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), CorMedix Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is CorMedix Inc.'s debt ratio?
CorMedix Inc.'s debt ratio is 0.1% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.4%.
What are CorMedix Inc.'s key financial metrics?
CorMedix Inc. has a market capitalization of $530M, trailing P/E ratio of 3.3, and revenue of $312M. The company maintains a gross margin of 92.9% and a net margin of 52.3%. Return on equity stands at 66.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.